The Cure Ovarian Cancer Foundation funds early-detection research and supports women and families facing ovarian cancer.https://www.cureoc.com/https://www.cureoc.com/blog/ovarian-cancer-vaccines-on-the-horizon/https://www.cureoc.com/blog/ovarian-cancer-vaccines-on-the-horizon/Two vaccines are in development — one to stop recurrence, with over 50% of women alive eight years later, and one to prevent the disease entirely in BRCA carriers.Sat, 01 Aug 2026 07:00:00 GMThttps://www.cureoc.com/blog/why-ovarian-cancer-resists-chemo/https://www.cureoc.com/blog/why-ovarian-cancer-resists-chemo/Four studies this month reframed drug resistance: the tumor recruits your own immune cells, signals its neighbors to spread, and weaponizes its own acidity.Thu, 30 Jul 2026 07:00:00 GMThttps://www.cureoc.com/blog/asco-2026-ovarian-cancer-trial-results/https://www.cureoc.com/blog/asco-2026-ovarian-cancer-trial-results/A 35% reduction in the risk of death, a surprising answer about surgery timing, and a lesson in why "the tumor shrank" is not the same as "she lived longer."Thu, 25 Jun 2026 07:00:00 GMThttps://www.cureoc.com/blog/car-t-therapy-ovarian-cancer-milestone/https://www.cureoc.com/blog/car-t-therapy-ovarian-cancer-milestone/Women given months to live are passing one and two years on a cell therapy trial. Now the dose is going up, and Stanford is reporting early signals of its own.Wed, 27 May 2026 07:00:00 GMThttps://www.cureoc.com/blog/cholesterol-pathway-discovery-aacr-2026/https://www.cureoc.com/blog/cholesterol-pathway-discovery-aacr-2026/At AACR 2026, University of Florida researchers showed that cutting off one enzyme in the cholesterol assembly line does not just slow ovarian cancer cells — it kills them.Tue, 28 Apr 2026 07:00:00 GMThttps://www.cureoc.com/blog/ovarian-cancer-awareness-month-2026/https://www.cureoc.com/blog/ovarian-cancer-awareness-month-2026/Advocates took the fight to Westminster this March. Behind the teal ribbons sits a number worth celebrating: ovarian cancer trials nearly doubled last year.Tue, 24 Mar 2026 07:00:00 GMThttps://www.cureoc.com/blog/fda-approves-immunotherapy-for-platinum-resistant-ovarian-cancer/https://www.cureoc.com/blog/fda-approves-immunotherapy-for-platinum-resistant-ovarian-cancer/On February 10, the FDA approved the first immunotherapy regimen for platinum-resistant ovarian cancer — plus two "breakthrough" drugs moving up close behind it.Thu, 26 Feb 2026 08:00:00 GMT